It is not surprising that anti-TNF-α drugs (adalimumab (A), certolizumab pegol (C), etanercept (E), golimumab (G), and infliximab (I)) are considered anti-COVID-19 treatments [152,153,154,155,156,157] (Table 1). Here, TNF is linked to COVID-19.